Health AI Investment Doubles, Surpassing $3.7 Billion
The latest report from Menlo Partners reveals a dramatic surge in health AI investment, with total spending doubling to an impressive $3.7 billion. This significant increase solidifies healthcare as the largest vertical for AI adoption.
The surge is primarily fueled by provider organizations actively investing in advanced AI solutions designed to enhance both clinical and administrative workflows.
Table of Contents
This burgeoning market indicates a clear trend: healthcare providers are moving beyond basic AI applications. The focus is shifting towards more sophisticated tools that promise substantial improvements in efficiency and patient care.
The doubling of investment underscores the growing recognition of AI’s transformative potential within the sector.
Provider Focus Shifts to Clinical Copilots and Front-Office AI
Provider organizations are spearheading this investment wave, with a pronounced interest in deploying AI for clinical copilots and front-office operations. These areas represent the most popular new avenues for AI integration, according to the report.
This strategic shift highlights a desire to leverage AI for more direct patient interaction and provider support.
While established health IT companies continue to lead in areas like ambient scribing, providers are increasingly turning to innovative startups for cutting-edge AI-driven tools.
This trend suggests a growing appetite for specialized solutions that can address specific pain points in clinical and administrative tasks, moving beyond the capabilities of traditional Electronic Health Record (EHR) systems.
AI Expansion Beyond Ambient Scribing
The findings indicate that provider interest in AI extends well beyond ambient scribing, a use case that has seen steady, albeit less explosive, growth. AI tools addressing administrative tasks such as coding and billing remain popular, but the healthcare AI landscape is rapidly expanding into more complex domains.
These expanding areas include crucial functions like clinical decision support, drug discovery, and sophisticated patient interactions. These are areas traditionally requiring significant human expertise, demonstrating AI’s growing capacity to augment or even automate high-level cognitive tasks within healthcare settings.
Clinical Copilots and Patient Engagement Drive 5x Growth
The report highlights a remarkable five-fold growth in AI uses such as clinical copilots and patient engagement/front-office functions. These areas have seen investment climb to approximately $550 million and $450 million, respectively.
This rapid expansion is particularly significant as providers account for the vast majority (77%) of overall healthcare AI spending.
Interestingly, providers appear more willing to adopt AI solutions from startups in these burgeoning areas compared to core EHR functions. While over two-thirds prefer to keep coding, billing, and chart review within their existing EHR systems, a substantial 16% are open to AI for patient navigation, indicating a clear preference for specialized, external solutions in patient-facing roles.
Startups Innovate in Prior Authorization and Patient Monitoring
The competitive landscape sees AI startups making significant inroads, particularly in areas where providers are open to new vendors. For instance, OpenEvidence is a leading choice for clinical copilots. Furthermore, regulatory sandboxes, such as Utah’s, are enabling startups like Doctronic to process prescription renewals for a wide array of medications.
The potential for AI in continuous patient care is also being realized through initiatives like ARPA-H’s $62.7 million investment. This funding aims to develop 24/7 AI agents capable of monitoring heart failure patients between visits, with the ultimate goal of achieving FDA approval.
This represents a significant step towards proactive and continuous healthcare management powered by AI.
Incumbents Dominate Ambient Scribing, Startups Expand Scope
Despite the growth in other areas, established health IT giants are solidifying their dominance in ambient scribing. By 2026, legacy vendors like Microsoft (Dragon Copilot) and Epic (Art) captured 68% of new ambient scribing revenue, now holding a substantial 46% market share. This trend has pushed AI startups to diversify their offerings and explore new market segments.
To counter this, startups are forging strategic partnerships. Abridge, for example, has collaborated with Availity to develop real-time prior authorization solutions.
Similarly, Heidi has partnered with R1 to integrate payer prior authorization policies directly into the clinical encounter workflow. These moves demonstrate a strategic pivot to leverage AI for critical administrative efficiencies, expanding beyond the increasingly competitive ambient scribing market.
Source: MedTech Dive

